AbbVie ABBV
NYSE ABBV
$285.37 +1.97 (+0.70%)
As of: Oct 16, 2026 · 3:59 PM EDT

AbbVie (ABBV) Profit After Tax (2012 - 2026)

Updated

AbbVie (ABBV) recorded Profit After Tax of $3.62 billion in Q2 2026, up 284.3% from $941 million a year earlier and up 418.8% from the prior quarter.

Analysis

AbbVie (ABBV) Profit After Tax (2012 - 2026) Analysis & Trends

On a TTM basis, AbbVie's Profit After Tax came in at $6.32 billion as of Jun 30, 2026, up 67.5% year-over-year; for FY2025, it came in at $4.23 billion, down 1.2% from FY2024.

  • Annual Profit After Tax has declined for three straight years, with a five-year compound annual growth rate of -1.7% (FY2020 to FY2025).
  • Across earlier years, Profit After Tax came in at $4.29 billion in FY2024 (-12.0%), $4.87 billion in FY2023 (-58.9%), $11.85 billion in FY2022 (+2.6%) and $11.55 billion in FY2021 (+149.9%).
  • The Q2 2026 figure is the highest quarterly Profit After Tax since Q3 2022.
  • On a year-over-year basis, Profit After Tax rose in 1 of the last six quarters, with growth averaging 16.8%.
  • Peak year-over-year performance for Profit After Tax in the last five years was growth of 284.3% in Q2 2026, against a decline of 88.0% in Q3 2025 at the low end.
  • Per Business Quant, the preceding three quarters came in at $697 million (Q1 2026), $1.82 billion (Q4 2025) and $188 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT (Qtr)
1 Eli Lilly 1,122.91 Bn 1,091.50 Bn 19.71 Bn 7.10 Bn
2 Johnson & Johnson 615.09 Bn 533.62 Bn 17.26 Bn 5.53 Bn
3 AbbVie 504.75 Bn 477.86 Bn 12.70 Bn 3.62 Bn
4 Merck 360.18 Bn 314.55 Bn 12.21 Bn -1.34 Bn
5 Novartis Ag 292.05 Bn 256.04 Bn 11.24 Bn 3.26 Bn
6 Astrazeneca 256.09 Bn 229.78 Bn 12.86 Bn 2.51 Bn
7 Amgen 233.63 Bn 189.02 Bn 7.24 Bn 2.38 Bn
8 Gilead Sciences 194.49 Bn 168.69 Bn 6.22 Bn -10.50 Bn
9 Pfizer 168.35 Bn 114.99 Bn 10.94 Bn -246.00 Mn
10 Vertex Pharmaceuticals 126.70 Bn 98.70 Bn 2.84 Bn 1.10 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.62 Bn
Mar 31, 2026 697.00 Mn
Dec 31, 2025 1.82 Bn
Sep 30, 2025 188.00 Mn
Jun 30, 2025 941.00 Mn
Mar 31, 2025 1.29 Bn
Dec 31, 2024 -23.00 Mn
Sep 30, 2024 1.56 Bn
Jun 30, 2024 1.37 Bn
Mar 31, 2024 1.37 Bn
Dec 31, 2023 824.00 Mn
Sep 30, 2023 1.78 Bn
Jun 30, 2023 2.03 Bn
Mar 31, 2023 475.00 Mn
Dec 31, 2022 2.47 Bn
Sep 30, 2022 3.95 Bn
Jun 30, 2022 928.00 Mn
Mar 31, 2022 4.49 Bn
Dec 31, 2021 4.05 Bn
Sep 30, 2021 3.18 Bn
API Access

AbbVie Profit After Tax API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=profit-after-tax&ticker=ABBV&period=max&api_key=YOUR_API_KEY